Daiwa Securities Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Sell |
|
|||||
|
2025
Q1 | $1.19M | Buy |
|
|||||
|
2024
Q4 | $1.11M | Sell |
|
|||||
|
2024
Q3 | $1.36M | Buy |
|
|||||
|
2024
Q2 | $1.21M | Buy |
|
|||||
|
2024
Q1 | $1.19M | Buy |
|
|||||
|
2023
Q4 | $854K | Buy |
|
|||||
|
2023
Q3 | $678K | Hold |
|
|||||
|
2023
Q2 | $569K | Buy |
|
|||||
|
2023
Q1 | $584K | Buy |
|
|||||
|
2022
Q4 | $665K | Sell |
|
|||||
|
2022
Q3 | $920K | Sell |
|
|||||
|
2022
Q2 | $853K | Sell |
|
|||||
|
2022
Q1 | $964K | Sell |
|
|||||
|
2021
Q4 | $880K | Sell |
|
|||||
|
2021
Q3 | $1.04M | Buy |
|
|||||
|
2021
Q2 | $1.04M | Sell |
|
|||||
|
2021
Q1 | $1.06M | Sell |
|
|||||
|
2020
Q4 | $1.06M | Buy |
|
|||||
|
2020
Q3 | $843K | Sell |
|
|||||
|
2020
Q2 | $866K | Hold |
|
|||||
|
2020
Q1 | $1.23M | Sell |
|
|||||
|
2019
Q4 | $1.69M | Sell |
|
|||||
|
2019
Q3 | $1.94M | Sell |
|
|||||
|
2019
Q2 | $2M | Sell |
|
|||||
|
2019
Q1 | $2.43M | Sell |
|
|||||
|
2018
Q4 | $2.39M | Sell |
|
|||||
|
2018
Q3 | $4.45M | Sell |
|
|||||
|
2018
Q2 | $4.84M | Sell |
|
|||||
|
2018
Q1 | $5.26M | Buy |
|
|||||
|
2017
Q4 | $4.83M | Buy |
|